Genfleet Therapeutics

Developer of drugs for treating tumors and autoimmune diseases

placePudong, Shanghai, China calendar_todayFounded 2017 language genfleet.com

Social engagement

Social engagement: 848 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

23 investors on record; lead investors include Ally Bridge Group, CDH, Shenzhen Capital Group, Huagai Capital.

Investor typeCountShare
Venture capital1148%
Private equity730%
Bank & private debt14%
Other / undisclosed417%

Recent activity

22 Sep 2025
Milestone
revenue
31 Jul 2025
Milestone
regulatory
Coming soon